InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
15
T+90 hit rate
83%
T+90 mean return
+7.5%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Arbuckle Stuart A, Chief Executive Officer. Insider active across 6 companies, notably VERTEX PHARMACEUTICALS INC / MA. Aggregated, 53 reports have been recorded. Split: 0 buy · 15 sells. Total volume traded: €1.8m. History available since 17 May 2021. The latest transaction was filed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations53 total
4,712 sharesCommon StockSEC:0001104659-26-077863:0
1,371 sharesCommon StockSEC:0001689548-26-000064:0
671 shares0Common StockSEC:0001178670-26-000034:0
688 shares0Common StockSEC:0001689548-26-000018:0
478 shares0Common StockSEC:0001689548-26-000018:1
37,622 shares0Common StockSEC:0000875320-25-000196:0
7,071 shares@ US$479.6112.7% of flowCommon StockSEC:0000875320-25-000124:0
4,716 shares@ US$483.288.6% of flowCommon StockSEC:0000875320-25-000105:0
2,724 shares@ US$463.464.7% of flowCommon StockSEC:0000875320-25-000081:0
7,903 shares0Common StockSEC:0000875320-25-000059:0
3,220 shares@ US$467.985.7% of flowCommon StockSEC:0000875320-25-000035:0
14,624 shares0Common StockSEC:0000875320-25-000009:0
3,000 sharesCommon StockSEC:0001104659-24-074770:0
69 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000152:0
4,714 shares@ US$431.797.4% of flowCommon StockSEC:0000875320-24-000099:0
3,603 shares@ US$421.775.5% of flowCommon StockSEC:0000875320-24-000087:0
4,499 shares@ US$424.017.0% of flowCommon StockSEC:0000875320-24-000068:0
3,177 shares@ US$422.744.9% of flowCommon StockSEC:0000875320-24-000043:0
5,381 sharesCommon StockSEC:0001104659-24-014706:0
6,976 shares0Common StockSEC:0000875320-24-000018:0
442 shares@ US$29.6524.5% of flowCommon StockSEC:0001415889-24-000373:0
8,603 shares@ US$187.535.9% of flowCommon StockSEC:0000875320-23-000056:0
827 shares@ US$15.8725.7% of flowCommon StockSEC:0001415889-23-013758:0
695 shares@ US$18.8724.9% of flowCommon StockSEC:0001415889-23-010823:0
8,603 shares@ US$187.535.8% of flowCommon StockSEC:0001209191-23-038343:0
25 of 53 declarations
About Arbuckle Stuart A
Arbuckle Stuart A is the EVP, COO at VERTEX PHARMACEUTICALS INC / MA. He oversees the company's operations and plays a key role in implementing the strategy. His expertise in the biopharmaceutical sector is essential for the development of the organization.
